197 related articles for article (PubMed ID: 22140093)
21. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
[TBL] [Abstract][Full Text] [Related]
22. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
[TBL] [Abstract][Full Text] [Related]
23. ATM activation and histone H2AX phosphorylation as indicators of DNA damage by DNA topoisomerase I inhibitor topotecan and during apoptosis.
Tanaka T; Kurose A; Huang X; Dai W; Darzynkiewicz Z
Cell Prolif; 2006 Feb; 39(1):49-60. PubMed ID: 16426422
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.
Rao VA; Fan AM; Meng L; Doe CF; North PS; Hickson ID; Pommier Y
Mol Cell Biol; 2005 Oct; 25(20):8925-37. PubMed ID: 16199871
[TBL] [Abstract][Full Text] [Related]
25. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.
Cristini A; Park JH; Capranico G; Legube G; Favre G; Sordet O
Nucleic Acids Res; 2016 Feb; 44(3):1161-78. PubMed ID: 26578593
[TBL] [Abstract][Full Text] [Related]
26. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Kaufmann SH
Cancer Res; 1991 Feb; 51(4):1129-36. PubMed ID: 1705167
[TBL] [Abstract][Full Text] [Related]
27. ATM is required for the repair of Topotecan-induced replication-associated double-strand breaks.
Köcher S; Spies-Naumann A; Kriegs M; Dahm-Daphi J; Dornreiter I
Radiother Oncol; 2013 Sep; 108(3):409-14. PubMed ID: 23928469
[TBL] [Abstract][Full Text] [Related]
28. Histone H2AX phosphorylation after cell irradiation with UV-B: relationship to cell cycle phase and induction of apoptosis.
Halicka HD; Huang X; Traganos F; King MA; Dai W; Darzynkiewicz Z
Cell Cycle; 2005 Feb; 4(2):339-45. PubMed ID: 15655354
[TBL] [Abstract][Full Text] [Related]
29. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
Tomicic MT; Kaina B
Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication.
Zhao H; Traganos F; Darzynkiewicz Z
Cytometry A; 2010 Mar; 77(3):285-93. PubMed ID: 20014310
[TBL] [Abstract][Full Text] [Related]
31. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
Tanizawa A; Kohn KW; Kohlhagen G; Leteurtre F; Pommier Y
Biochemistry; 1995 May; 34(21):7200-6. PubMed ID: 7766631
[TBL] [Abstract][Full Text] [Related]
32. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage.
Adachi N; So S; Koyama H
J Biol Chem; 2004 Sep; 279(36):37343-8. PubMed ID: 15218034
[TBL] [Abstract][Full Text] [Related]
33. Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
Goodenow D; Emmanuel F; Berman C; Sahyouni M; Richardson C
Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503144. PubMed ID: 32087851
[TBL] [Abstract][Full Text] [Related]
34. DNA damage response (DDR) via NKX3.1 expression in prostate cells.
Erbaykent-Tepedelen B; Karamil S; Gonen-Korkmaz C; Korkmaz KS
J Steroid Biochem Mol Biol; 2014 May; 141():26-36. PubMed ID: 24434284
[TBL] [Abstract][Full Text] [Related]
35. Most hydrogen peroxide-induced histone H2AX phosphorylation is mediated by ATR and is not dependent on DNA double-strand breaks.
Katsube T; Mori M; Tsuji H; Shiomi T; Wang B; Liu Q; Nenoi M; Onoda M
J Biochem; 2014 Aug; 156(2):85-95. PubMed ID: 24682951
[TBL] [Abstract][Full Text] [Related]
36. Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.
Regairaz M; Zhang YW; Fu H; Agama KK; Tata N; Agrawal S; Aladjem MI; Pommier Y
J Cell Biol; 2011 Nov; 195(5):739-49. PubMed ID: 22123861
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells.
D'Onofrio G; Tramontano F; Dorio AS; Muzi A; Maselli V; Fulgione D; Graziani G; Malanga M; Quesada P
Biochem Pharmacol; 2011 Jan; 81(2):194-202. PubMed ID: 20875401
[TBL] [Abstract][Full Text] [Related]
38. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
[TBL] [Abstract][Full Text] [Related]
39. Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines.
Janss AJ; Cnaan A; Zhao H; Shpilsky A; Levow C; Sutton L; Phillips PC
Anticancer Drugs; 1998 Aug; 9(7):641-52. PubMed ID: 9773809
[TBL] [Abstract][Full Text] [Related]
40. Numerical analysis of etoposide induced DNA breaks.
Muslimović A; Nyström S; Gao Y; Hammarsten O
PLoS One; 2009 Jun; 4(6):e5859. PubMed ID: 19516899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]